Fresh Recalls

SUN PHARMACEUTICAL INDUSTRIES recalls

11 recent recalls on record for SUN PHARMACEUTICAL INDUSTRIES in connected official government data as of October 22, 2026 at 12:00 PM UTC.

Models with recalls

Budesonide Inhalation Suspension (1)Carbamazepine Tablets (1)DOXOrubin Hydrochloride Liposome injection (1)Fexofenadine Hydrochloride Tablets (1)Nystatin Cream (1)Perampanel CIII Tablets (1)Tretinoin Cream UPS (1)Tretinoin Cream USP (2)Xyvona (levorphanol tartrate tablets) (2)

All SUN PHARMACEUTICAL INDUSTRIES recalls

FDA Class III · Drug · October 14, 2026

Tretinoin Cream UPS recall — SUN PHARMACEUTICAL INDUSTRIES INC

Failed Impurities/Degradation Specifications

Official ID D-0035-2027 · Official record ↗

FDA Class III · Drug · October 14, 2026

Tretinoin Cream USP recall — SUN PHARMACEUTICAL INDUSTRIES INC

Failed Impurities/Degradation Specifications

Official ID D-0034-2027 · Official record ↗

FDA Class III · Drug · October 14, 2026

Tretinoin Cream USP recall — SUN PHARMACEUTICAL INDUSTRIES INC

Failed Impurities/Degradation Specifications

Official ID D-0033-2027 · Official record ↗

FDA Not Yet Classified · Drug · September 23, 2026

Nystatin Cream recall — SUN PHARMACEUTICAL INDUSTRIES INC

Failed Stability Specifications

Official ID EVT-99876-z42zg7 · Official record ↗

FDA Class II · Drug · August 26, 2026

Carbamazepine Tablets recall — SUN PHARMACEUTICAL INDUSTRIES INC

CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

Official ID D-0770-2026 · Official record ↗

FDA Class III · Drug · July 8, 2026

Fexofenadine Hydrochloride Tablets recall — SUN PHARMACEUTICAL INDUSTRIES INC

Failed Impurities/Degradation Specifications

Official ID D-0654-2026 · Official record ↗

FDA Class II · Drug · July 1, 2026

Perampanel CIII Tablets recall — SUN PHARMACEUTICAL INDUSTRIES INC

Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

Official ID D-0628-2026 · Official record ↗

FDA Class II · Drug · June 17, 2026

Budesonide Inhalation Suspension recall — SUN PHARMACEUTICAL INDUSTRIES INC

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Official ID D-0607-2026 · Official record ↗

FDA Class I · Drug · June 17, 2026

DOXOrubin Hydrochloride Liposome injection recall — SUN PHARMACEUTICAL INDUSTRIES INC

Presence of Particulate matter: Particulate matter identified as glass.

Official ID D-0580-2026 · Official record ↗

FDA Class II · Drug · June 10, 2026

Xyvona (levorphanol tartrate tablets) recall — SUN PHARMACEUTICAL INDUSTRIES INC

Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

Official ID D-0599-2026 · Official record ↗

FDA Class II · Drug · June 10, 2026

Xyvona (levorphanol tartrate tablets) recall — SUN PHARMACEUTICAL INDUSTRIES INC

Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

Official ID D-0598-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 12:00 PM UTC.